Loading clinical trials...
Loading clinical trials...
This study aims to seek evidence that activation of certain cells of the immune system will be safe and well tolerated in combination with cytotoxic chemotherapy. Preliminary evidence of clinical anti...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hoffmann-La Roche
Collaborators
NCT07656571 · Pancreatic Neoplasms, Pancreatic Cancer
NCT05687123 · Metastatic Pancreatic Neuroendocrine Tumor, Pancreatic Neoplasm, and more
NCT06380816 · Advanced Solid Tumours, Squamous Cell Carcinoma of Head and Neck, and more
NCT07542041 · Pancreatic Cancer, Pancreatic Neoplasms, and more
NCT04406831 · Pancreatic Cancer Stage III, Pancreatic Cancer Stage IV, and more
Pfizer Investigational Site
Indianapolis, Indiana
Pfizer Investigational Site
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions